Innovating Works

BOEHRINGER INGELHEIM ANIMAL HEALTH FRANC...

Desconocido
VAC2VAC: Vaccine lot to Vaccine lot comparison by consistency testing. BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the l...
2016-04-14 - 2022-02-28 | Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE tramitó un FP6: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
2015-03-01 - 2020-02-29 | Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE tramitó un FP7: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
Financiado
ESNIP 3: European Surveillance Network for Influenza in Pigs 3 BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE participó en un FP7: This European surveillance network for influenza in pigs (ESNIP) 3 will maintain and expand surveillance networks established during previou...
Financiado
FMD-DISCONVAC: Development enhancement and complementation of animal sparing foot and mouth disease vaccine based... Foot-and-mouth disease (FMD) is one of the world’s most infectious diseases of livestock and continues to pose a significant threat to endem...
Financiado
STAR-IDAZ: Global Strategic Alliances for the Coordination of Research on the Major Infectious Diseases of Anim... BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE participó en un FP7: Animal diseases can cause serious social, economic and environmental damage and in some cases also threaten human health. An increasing numb...
Financiado
POSTICK: Post graduate training network for capacity building to control ticks and tick borne diseases BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE participó en un FP7: In the context of global warming and globalisation, tick and tick-borne diseases (TTBD) are expected to emerge, with an increasing risk for...
Financiado
ORBIVAC: Development of Vaccines for bTV EHDV and AHSV BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE participó en un FP7: The major outstanding challenges of orbivirus vaccine research is to develop vaccines that can afford a broad protective immune response aga...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.